0.46 (-1.70%)
As of Apr 27, 2023
Source:
We develop and commercialize point-of-care diagnostic tests used for the rapid detection and diagnosis of infectious diseases, including sexually transmitted disease, insect vector and tropical disease, COVID-19 and other viral and bacterial infections, enabling expedited treatment.
| Country | United States |
| Headquarters | hauppauge, new york |
| Phone Number | (631) 924-1135 |
| Industry | manufacturing |
| CEO | Richard L. Eberly |
| Website | chembio.com |